Use of 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds as analgesics

Details for Australian Patent Application No. 2012201628 (hide)

Owner Allergan, Inc.

Inventors Leblond, Bertrand; Beausoleil, Eric; Taverne, Thierry; Donello, John E.; Schweighoffer, Fabien (jacques)

Agent Davies Collison Cave

Pub. Number AU-A-2012201628

Parent 2006209197

Filing date 19 March 2012

Wipo publication date 5 April 2012

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

5 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201628

5 April 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201629-Flavor composition containing flavone glycosides

2012201627-Slow-maturing, determinate peas